AKT1 and cancer: Pivotal for both enhancing metabolism and protection, the transcription factor Nuclear erythroid factor 2-like (Nrf2), constitutively active in many cancer cell types, can redirect glucose and glutamine into anabolic pathways, including purine nucleotide generation in the presence of PI3K-Akt signaling [125].